Our platform technologies enable the harnessing of biological diversity for the rapid identification of biological starting points.
Selected reagents can provide insight into disease mechanisms, find biomarkers, and be developed into prospective drugs and diagnostics.
Isogenica is a discovery partner for companies developing novel biologics and diagnostics products.
To find out more abut our track record of successful partnerships visit our News section.
The speed at which we were able to transfer CIS Display in-house was impressive. Within two days we had the system running in our lab and had made our first selections.
VP Reagent Discovery , Global Clinical Diagnostics Company
Isogenica is a fantastic company to work with – dynamic, exciting and extremely capable.
Dr Anna Hine, Aston University and Inventor of Colibra™
Isogenica have proven their ability to make functional selections of key scaffolds, and we are expanding our collaboration.
Head of Biologics, Biotechnology Division of Top 10 Pharma